Literature DB >> 33718222

Development, Validation, and Visualization of A Web-Based Nomogram for Predicting the Recurrence-Free Survival Rate of Patients With Desmoid Tumors.

Haotian Liu1,2, Kai Huang3,4,5, Tao Li6, Tielong Yang1,2, Zhichao Liao1,2, Chao Zhang1,2, Lijie Xiang1,2, Yong Chen3,4, Jilong Yang1,2.   

Abstract

Background: Surgery is an important treatment option for desmoid tumor (DT) patients, but how to decrease and predict the high recurrence rate remains a major challenge.
Methods: Desmoid tumor patients diagnosed and treated at Tianjin Cancer Institute & Hospital were included, and a web-based nomogram was constructed by screening the recurrence-related risk factors using Cox regression analysis. External validation was conducted with data from the Fudan University Shanghai Cancer Center.
Results: A total of 385 patients were identified. Finally, after excluding patients without surgery, patients who were lost to follow-up, and patients without complete resection, a total of 267 patients were included in the nomogram construction. Among these patients, 53 experienced recurrence, with a recurrence rate of 20.15%. The 3-year and 5-year recurrence-free survival (RFS) rates were 82.5% and 78%, respectively. Age, tumor diameter, admission status, location, and tumor number were correlated with recurrence in univariate Cox analysis. In multivariate Cox analysis, only age, tumor diameter and tumor number were independent risk factors for recurrence and were then used to construct a web-based nomogram to predict recurrence. The concordance index (C-index) of the nomogram was 0.718, and the areas under the curves (AUCs) of the 3-year and 5-year receiver operating characteristic (ROC) curves were 0.751 and 0.761, respectively. In the external validation set, the C-index was 0.706, and the AUCs of the 3-year and 5-year ROC curves are 0.788 and 0.794, respectively. Conclusions: Age, tumor diameter, and tumor number were independent predictors of recurrence for DTs, and a web-based nomogram containing these three predictors could accurately predict RFS (https://stepforward.shinyapps.io/Desmoidtumor/).
Copyright © 2021 Liu, Huang, Li, Yang, Liao, Zhang, Xiang, Chen and Yang.

Entities:  

Keywords:  desmoid tumor; prediction; recurrence; the web-based nomogram; tumor number; validation

Year:  2021        PMID: 33718222      PMCID: PMC7947817          DOI: 10.3389/fonc.2021.634648

Source DB:  PubMed          Journal:  Front Oncol        ISSN: 2234-943X            Impact factor:   6.244


  38 in total

1.  Radiotherapy in desmoid tumors : Treatment response, local control, and analysis of local failures.

Authors:  Kirsi Santti; Annette Beule; Laura Tuomikoski; Mikko Rönty; Anna-Stina Jääskeläinen; Kauko Saarilahti; Hanna Ihalainen; Maija Tarkkanen; Carl Blomqvist
Journal:  Strahlenther Onkol       Date:  2017-01-02       Impact factor: 3.621

2.  Prognostic factors for the recurrence of sporadic desmoid-type fibromatosis after macroscopically complete resection: Analysis of 114 patients at a single institution.

Authors:  X D He; Y B Zhang; L Wang; M L Tian; W Liu; Q Qu; B L Li; T Hong; N C Li; Y Q Na
Journal:  Eur J Surg Oncol       Date:  2015-05-13       Impact factor: 4.424

3.  Clinical outcomes of systemic therapy for patients with deep fibromatosis (desmoid tumor).

Authors:  Veridiana Pires de Camargo; Mary L Keohan; David R D'Adamo; Cristina R Antonescu; Murray F Brennan; Samuel Singer; Linda S Ahn; Robert G Maki
Journal:  Cancer       Date:  2010-05-01       Impact factor: 6.860

4.  Long-term diagnostic value of MRI in detecting recurrent aggressive fibromatosis at two multidisciplinary sarcoma centers.

Authors:  Sam Sedaghat; Maya Sedaghat; Sebastian Krohn; Olav Jansen; Kai Freund; Arne Streitbürger; Benjamin Reichardt
Journal:  Eur J Radiol       Date:  2020-11-12       Impact factor: 3.528

Review 5.  Desmoid-Type Fibromatosis: Who, When, and How to Treat.

Authors:  Javier Martínez Trufero; Isabel Pajares Bernad; Irene Torres Ramón; Jorge Hernando Cubero; Roberto Pazo Cid
Journal:  Curr Treat Options Oncol       Date:  2017-05

6.  Radiation Therapy for Aggressive Fibromatosis: The Association Between Local Control and Age.

Authors:  James E Bates; Christopher G Morris; Nicole M Iovino; Michael Rutenberg; Robert A Zlotecki; C Parker Gibbs; Mark Scarborough; Daniel J Indelicato
Journal:  Int J Radiat Oncol Biol Phys       Date:  2017-12-21       Impact factor: 7.038

7.  Desmoid-type fibromatosis and pregnancy: a multi-institutional analysis of recurrence and obstetric risk.

Authors:  Marco Fiore; Sara Coppola; Amanda J Cannell; Chiara Colombo; Monica M Bertagnolli; Suzanne George; Axel Le Cesne; Rebecca A Gladdy; Paolo G Casali; Carol J Swallow; Alessandro Gronchi; Sylvie Bonvalot; Chandrajit P Raut
Journal:  Ann Surg       Date:  2014-05       Impact factor: 12.969

8.  Desmoid tumor mimics local recurrence of extremity sarcoma on MRI.

Authors:  Samir Sabharwal; Shivani Ahlawat; Adam S Levin; Christian F Meyer; Eugene Brooks; John Ligon; Carol D Morris
Journal:  J Surg Oncol       Date:  2020-03-24       Impact factor: 3.454

Review 9.  Aggressive fibromatosis.

Authors:  Cyril Fisher; Khin Thway
Journal:  Pathology       Date:  2014-02       Impact factor: 5.306

Review 10.  Activated Signaling Pathways and Targeted Therapies in Desmoid-Type Fibromatosis: A Literature Review.

Authors:  Milea J M Timbergen; Ron Smits; Dirk J Grünhagen; Cornelis Verhoef; Stefan Sleijfer; Erik A C Wiemer
Journal:  Front Oncol       Date:  2019-05-17       Impact factor: 6.244

View more
  1 in total

Review 1.  Evolving strategies for management of desmoid tumor.

Authors:  Richard F Riedel; Mark Agulnik
Journal:  Cancer       Date:  2022-06-07       Impact factor: 6.921

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.